-
公开(公告)号:US5556767A
公开(公告)日:1996-09-17
申请号:US173209
申请日:1993-12-22
申请人: Craig A. Rosen , Haodong Li , Steven Ruben , Mark D. Adams
发明人: Craig A. Rosen , Haodong Li , Steven Ruben , Mark D. Adams
CPC分类号: C07K14/523 , C07K16/24 , A61K38/00
摘要: There is disclosed a human macrophage inflammatory protein-1 .gamma. (MIP-1 .gamma.) polypeptide and DNA(RNA) encoding such polypeptide. There is also provided a procedure for producing such polypeptide by recombinant techniques and for producing an antibody against such polypeptide. Another aspect of the invention provides a combination of the polypeptide of the present invention and a suitable pharmaceutical carrier for providing a therapeutically effective amount of the polypeptide for the treatment of various associated diseases.
摘要翻译: 公开了人巨噬细胞炎症蛋白-1(MIP-1γ)多肽和编码这种多肽的DNA(RNA)。 还提供了通过重组技术产生这种多肽并产生针对这种多肽的抗体的方法。 本发明的另一方面提供本发明的多肽和合适的药物载体的组合,用于提供治疗有效量的多肽用于治疗各种相关疾病。
-
公开(公告)号:US5958400A
公开(公告)日:1999-09-28
申请号:US766620
申请日:1996-12-13
申请人: Steven Ruben , Haodong Li , Mark D. Adams
发明人: Steven Ruben , Haodong Li , Mark D. Adams
IPC分类号: G01N33/50 , A61K31/70 , A61K31/7088 , A61K38/00 , A61K45/00 , A61K48/00 , A61P3/10 , A61P7/00 , A61P7/04 , A61P9/00 , A61P29/00 , A61P31/00 , A61P31/12 , A61P35/00 , A61P35/02 , A61P37/02 , A61P43/00 , C07H21/04 , C07K14/54 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/09 , C12P21/02 , C12Q1/02 , C12Q1/68 , C12R1/19 , G01N33/15 , G01N33/566 , A61K38/20 , C12N15/24 , C12N15/63
CPC分类号: C07K14/5412 , A61K38/00 , A61K48/00
摘要: Polynucleotides which encode the polypeptide IL-6SV, as well as such polypeptides, antibodies and antagonist inhibitors against the polypeptide and the use of the polypeptide as a pharmaceutical for treating cancer, auto-immune diseases, platelet reducing conditions, anemias, bone marrow and organ transplantation.
摘要翻译: 编码多肽IL-6SV的多核苷酸,以及针对多肽的多肽,抗体和拮抗剂抑制剂以及多肽作为治疗癌症的药物,自身免疫疾病,血小板减少病症,贫血,骨髓和器官的用途 移植。
-
公开(公告)号:US5641657A
公开(公告)日:1997-06-24
申请号:US246427
申请日:1994-05-19
申请人: Steven Ruben , Haodong Li , Mark D. Adams
发明人: Steven Ruben , Haodong Li , Mark D. Adams
IPC分类号: G01N33/50 , A61K31/70 , A61K31/7088 , A61K38/00 , A61K45/00 , A61K48/00 , A61P3/10 , A61P7/00 , A61P7/04 , A61P9/00 , A61P29/00 , A61P31/00 , A61P31/12 , A61P35/00 , A61P35/02 , A61P37/02 , A61P43/00 , C07H21/04 , C07K14/54 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N15/09 , C12P21/02 , C12Q1/02 , C12Q1/68 , C12R1/19 , G01N33/15 , G01N33/566 , C12N15/24
CPC分类号: C07K14/5412 , A61K38/00 , A61K48/00
摘要: Polynucleotides which encode the polypeptide IL-6SV, as well as such polypeptides, antibodies and antagonist inhibitors against the polypeptide and the use of the polypeptide as a pharmaceutical for treating cancer, auto-immune diseases, platelet reducing conditions, anemias, bone marrow and organ transplantation.
摘要翻译: 编码多肽IL-6SV的多核苷酸,以及针对多肽的多肽,抗体和拮抗剂抑制剂以及多肽作为治疗癌症的药物,自身免疫疾病,血小板减少病症,贫血,骨髓和器官的用途 移植。
-
4.
公开(公告)号:US07364865B2
公开(公告)日:2008-04-29
申请号:US11381977
申请日:2006-05-05
申请人: Reiner L. Gentz , Brent L. Kreider , Jun Zhang , Michael Antonaccio , Donna Mendrick , Pablo Jimenez , Vikram Patel , Craig A. Rosen , Mark D. Adams , Haodong Li , Steven M. Ruben
发明人: Reiner L. Gentz , Brent L. Kreider , Jun Zhang , Michael Antonaccio , Donna Mendrick , Pablo Jimenez , Vikram Patel , Craig A. Rosen , Mark D. Adams , Haodong Li , Steven M. Ruben
CPC分类号: G01N33/6863 , A61K38/00 , A61K48/00 , C07K1/113 , C07K1/36 , C07K14/50 , C07K14/521 , C07K14/523 , C07K16/24 , C07K2319/00 , C12N15/72 , C12N2799/026 , G01N2333/52
摘要: There are disclosed therapeutic compositions and methods using isolated nucleic acid molecules encoding a human myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptide (previously termed MIP-3 and chemokine β8 (CKβ8 or ckb-8)); a human monocyte-colony inhibitory factor (M-CIF) polypeptide (previously termed MIP1-γ and chemokine β1(CKβ1 or ckb-1)), and a macrophage inhibitory protein-4 (MIP-4), as well as MPIF-1, M-CIF and/or MIP-4 polypeptides themselves, as are vectors, host cells and recombinant methods for producing the same.
摘要翻译: 公开了使用编码人骨髓祖细胞抑制因子-1(MPIF-1)多肽(以前称为MIP-3和趋化因子β8(CKbeta8或ckb-8))的分离的核酸分子的治疗组合物和方法。 人单核细胞集落抑制因子(M-CIF)多肽(以前称为MIP1-γ和趋化因子β1(CKbeta1或ckb-1))和巨噬细胞抑制蛋白-4(MIP-4)以及MPIF-1 ,M-CIF和/或MIP-4多肽本身,以及用于产生它们的载体,宿主细胞和重组方法。
-
公开(公告)号:US07097985B2
公开(公告)日:2006-08-29
申请号:US10329472
申请日:2002-12-27
申请人: Haodong Li , Mark D. Adams
发明人: Haodong Li , Mark D. Adams
CPC分类号: C07K16/24 , A61K38/00 , A61K2039/505 , C07K14/523 , G01N33/564 , G01N33/57426 , G01N33/6863 , G01N2333/52
摘要: Human Ckβ-9 polypeptides and DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ckβ-9 polypeptides for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis. Antagonists against such polypeptides and their use as a therapeutic to treat rheumatoid arthritis, autoimmune and chronic inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever and bone marrow failure are also disclosed. Diagnostic assays are also disclosed which detect the presence of mutations in the Ckβ-9 coding sequence and over-expression of the Ckβ-9 protein.
摘要翻译: 公开了人Ckbeta-9多肽和编码这种趋化因子多肽的DNA(RNA)和通过重组技术产生这种多肽的方法。 还公开了利用这种Ckbeta-9多肽治疗白血病,肿瘤,慢性感染,自身免疫疾病,纤维化病症,伤口愈合和牛皮癣的方法。 还公开了抗这些多肽的拮抗剂及其作为治疗类风湿性关节炎,自身免疫性和慢性炎性和感染性疾病,过敏反应,前列腺素不依赖性发烧和骨髓衰竭的治疗剂的用途。 还公开了诊断测定法,其检测Ckbeta-9编码序列中突变的存在和Ckbeta-9蛋白的过表达。
-
公开(公告)号:US06534630B1
公开(公告)日:2003-03-18
申请号:US09348815
申请日:1999-07-08
申请人: Haodong Li , Mark D. Adams
发明人: Haodong Li , Mark D. Adams
IPC分类号: C07K100
CPC分类号: C07K14/475 , A61K38/00 , A61K48/00 , A61K2039/505 , C07K2319/00
摘要: The present invention relates to a human CTGF-2 polypeptide and DNA (RNA) encoding such polypeptide. Also provided is a procedure for producing such polypeptide by recombinant techniques and antibodies and antagonist/inhibitors against such polypeptide. Also provided are methods of using the polypeptide therapeutically for enhancing the repair of connective and support tissue, promoting the attachment, fixation and stabilization of tissue implants and enhancing wound healing. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention are also disclosed.
-
公开(公告)号:US07851596B2
公开(公告)日:2010-12-14
申请号:US12111079
申请日:2008-04-28
申请人: Reiner L. Gentz , Brent L. Kreider , Jun Zhang , Michael Antonaccio , Donna Mendrick , Pablo Jimenez , Vikram Patel , Craig A. Rosen , Mark D. Adams , Haodong Li , Steven M. Ruben
发明人: Reiner L. Gentz , Brent L. Kreider , Jun Zhang , Michael Antonaccio , Donna Mendrick , Pablo Jimenez , Vikram Patel , Craig A. Rosen , Mark D. Adams , Haodong Li , Steven M. Ruben
IPC分类号: C07K14/52
CPC分类号: G01N33/6863 , A61K38/00 , A61K48/00 , C07K1/113 , C07K1/36 , C07K14/50 , C07K14/521 , C07K14/523 , C07K16/24 , C07K2319/00 , C12N15/72 , C12N2799/026 , G01N2333/52
摘要: There are disclosed therapeutic compositions and methods using isolated nucleic acid molecules encoding a human myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptide (previously termed MIP-3 and chemokine β8 (CKβ8 or ckb-8)); a human monocyte-colony inhibitory factor (M-CIF) polypeptide (previously termed MIP1-γ and chemokine β1 (CKβ1 or ckb-1)), and a macrophage inhibitory protein-4 (MIP-4), as well as MPIF-1, M-CIF and/or MIP-4 polypeptides themselves, as are vectors, host cells and recombinant methods for producing the same.
摘要翻译: 公开了使用编码人骨髓祖细胞抑制因子-1(MPIF-1)多肽(以前称为MIP-3和趋化因子8(CK&bgr; 8或ckb-8))的分离的核酸分子的治疗组合物和方法; 人类单核细胞集落抑制因子(M-CIF)多肽(以前称为MIP1-γ和趋化因子1(CK&bgr; 1或ckb-1))和巨噬细胞抑制蛋白-4(MIP-4) 作为MPIF-1,M-CIF和/或MIP-4多肽本身,载体,宿主细胞和用于制备它们的重组方法也是如此。
-
公开(公告)号:US20100041136A1
公开(公告)日:2010-02-18
申请号:US12579542
申请日:2009-10-15
申请人: Haodong Li , Mark D. Adams
发明人: Haodong Li , Mark D. Adams
CPC分类号: C07K14/475 , A61K38/00 , A61K48/00 , A61K2039/505 , C07K2319/00
摘要: The present invention relates to a human CTGF-2 polypeptide and DNA (RNA) encoding such polypeptide. Also provided is a procedure for producing such polypeptide by recombinant techniques and antibodies and antagonist/inhibitors against such polypeptide. Also provided are methods of using the polypeptide therapeutically for enhancing the repair of connective and support tissue, promoting the attachment, fixation and stabilization of tissue implants and enhancing wound healing. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention are also disclosed.
摘要翻译: 本发明涉及人CTGF-2多肽和编码这种多肽的DNA(RNA)。 还提供了通过重组技术产生这种多肽的方法和针对这种多肽的抗体和拮抗剂/抑制剂。 还提供了用于治疗性地增强连接和支持组织的修复,促进组织植入物的附着,固定和稳定以及增强伤口愈合的方法。 还公开了用于鉴定编码本发明多肽的核酸序列中突变和用于检测本发明多肽的改变水平的诊断测定。
-
公开(公告)号:US07183081B2
公开(公告)日:2007-02-27
申请号:US10893995
申请日:2004-07-20
申请人: Haodong Li , Mark D. Adams
发明人: Haodong Li , Mark D. Adams
IPC分类号: C12P21/06
CPC分类号: C07K14/521 , A61K38/00 , G01N33/564 , G01N2500/04 , G01N2800/26
摘要: Human chemokine polypeptides and DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis. Antagonists against such chemokine polypeptides and their use as a therapeutic to treat rheumatoid arthritis, autoimmune and chronic inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever and bone marrow failure are also disclosed. Diagnostic assays for identifying mutations in nucleic acid sequence encoding a polypeptide of the present invention and for detecting altered levels of the polypeptide of the present invention are also disclosed.
摘要翻译: 公开了人趋化因子多肽和编码这种趋化因子多肽的DNA(RNA)和通过重组技术产生此类多肽的方法。 还公开了利用这种趋化因子多肽治疗白血病,肿瘤,慢性感染,自身免疫疾病,纤维化病症,伤口愈合和牛皮癣的方法。 还公开了抗这种趋化因子多肽的拮抗剂及其作为治疗类风湿性关节炎,自身免疫性和慢性炎性和感染性疾病,过敏反应,前列腺素依赖性发烧和骨髓衰竭的治疗剂的用途。 还公开了用于鉴定编码本发明多肽的核酸序列中突变和用于检测本发明多肽的改变水平的诊断测定。
-
公开(公告)号:US07041460B2
公开(公告)日:2006-05-09
申请号:US10626530
申请日:2003-07-25
申请人: Reiner L. Gentz , Brent L. Kreider , Jun Zhang , Michael Antonaccio , Donna Mendrick , Pablo Jimenez , Vikram Patel , Craig A. Rosen , Mark D. Adams , Haodong Li , Steven M. Ruben
发明人: Reiner L. Gentz , Brent L. Kreider , Jun Zhang , Michael Antonaccio , Donna Mendrick , Pablo Jimenez , Vikram Patel , Craig A. Rosen , Mark D. Adams , Haodong Li , Steven M. Ruben
CPC分类号: G01N33/6863 , A61K38/00 , A61K48/00 , C07K1/113 , C07K1/36 , C07K14/50 , C07K14/521 , C07K14/523 , C07K16/24 , C07K2319/00 , C12N15/72 , C12N2799/026 , G01N2333/52
摘要: There are disclosed therapeutic compositions and methods using isolated nucleic acid molecules encoding a human myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptide (previously termed MIP-3 and chemokine β8 (CKβ8 or ckb-8)); a human monocyte-colony inhibitory factor (M-CIF) polypeptide (previously termed MIP1-γ and chemokine β1 (CKβ1 or ckb-1)), and a macrophage inhibitory protein-4 (MIP-4), as well as MPIF-1, M-CIF and/or MIP-4 polypeptides themselves, as are vectors, host cells and recombinant methods for producing the same.
摘要翻译: 公开了使用编码人骨髓祖细胞抑制因子-1(MPIF-1)多肽(以前称为MIP-3和趋化因子β8(CKbeta8或ckb-8))的分离的核酸分子的治疗组合物和方法。 人单核细胞集落抑制因子(M-CIF)多肽(以前称为MIP1-γ和趋化因子β1(CKbeta1或ckb-1))和巨噬细胞抑制蛋白-4(MIP-4)以及MPIF-1 ,M-CIF和/或MIP-4多肽本身,以及用于产生它们的载体,宿主细胞和重组方法。
-
-
-
-
-
-
-
-
-